Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2014

Business Wire


Transgenomic, Inc. (TBIO) today announced the following Webcast:

What: Transgenomic, Inc. Second Quarter 2014 Financial Results and Business Update Conference Call
When: Wednesday, August 6, 2014 @ 5:00 p.m. Eastern

How: Live over the Internet -- Simply log on to the web at the address above.
Contact: Investor Relations, 203-907-2293

To access the call via telephone, dial 866-952-1908 from the U.S. and Canada or 785-424-1827 for international participants and enter conference ID TRANS. A telephone replay will be available from 8:00 p.m. Eastern Time on August 6, 2014 through 11:59 p.m. Eastern Time on August 20, 2014 by dialing 800-723-1517 (domestic) or 402-220-2659 (international).

About Transgenomic, Inc.

Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCRTM and its unique genetic tests provided through its Patient Testing business. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies and sells equipment, reagents and other consumables for applications in molecular testing and cytogenetics. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.

Investor Contact
Argot Partners
Susan Kim, 212-600-1902
Media Contact
BLL Partners LLC
Barbara Lindheim, 212-584-2276
Company Contact
Transgenomic, Inc.
Mark Colonnese, 203-907-2242


View Comments (0)